{"title": "2022 Influenza and Pneumococcal Vaccines and Administration Reimbursement", "author": null, "url": null, "hostname": null, "description": null, "sitename": null, "date": "2022-03-10", "cleaned_text": "Vaccines and Administration Reimbursement The following services are paid at 100 percent of the established fee schedule amount. Coinsurance and the annual deductible do not apply. - Payment allowances for influenza vaccines are effective August 1, 2021, unless stated otherwise - Influenza and pneumococcal vaccine payment allowances are subject to change on a quarterly basis* - Administration payment allowances are updated annually on January 1 *Quarterly changes to influenza and pneumococcal vaccine payment allowances can be located on the [CMS website](http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Part-B-Drugs/McrPartBDrugAvgSalesPrice/index.html). Influenza, and Pneumococcal Administration Codes and Fees Following are the 2022 influenza and pneumococcal administration fees for dates of service January 1, 2022 through December 31, 2022. | | HCPCS Codes | | Description | | Ala. FSY 2022 Amount | | Tenn. FSY | | | | Admin influenza virus vac. | | $27.92 | | $27.70 | | $30.00 | | $27.72 | | G0009 | | Admin pneumococcal vaccine | | $27.92 | | $27.70 | | $30.00 | | $27.72 Influenza Virus Vaccine National Fees \u2014 Effective August 1, 2022 - July 31, 2023 The 2021/2022 flu season fees are listed below. Contractors are required to implement these fees no later than October 1, 2021. Palmetto GBA implemented the following fees on September 12, 2022, for dates of service August 1, 2022 and after. All claims processed and paid prior to September 12, 2022 will be automatically adjusted. No further action is required. |CPT\u00ae | Codes | | Description | | 08/01/22 - 7/31/23 Amount | | 90630* | | Flu vacc iiv4 no preserv id | | Pending | | 90653 | | Iiv adjuvant vaccine im | | Pending | | 90654* | | Flu vacc iiv3 no preserv id | | Pending | | 90655* | | Iiv3 vacc no prsv 0.25 ml im | | Pending | | 90656* | | Iiv3 vacc no prsv 0.5 ml im | | Pending | | 90657* | | Iiv3 vaccine splt 0.25 ml im | | Pending | | 90661* | | Cciiv3 vac no prsv 0.5 ml im | | Pending | | 90662 | | Iiv no prsv increased ag im | | $69.94 | | 90672 | | Laiv4 vaccine intranasal | | $26.88 | | 90673* | | Riv3 vaccine no preserv im | | Pending | | 90674 | | Cciiv4 vac no prsv 0.5 ml im | | $32.28 | | 90682 | | Riv4 vacc recombinant dna im | | $69.94 | | 90685* | | Iiv4 vacc no prsv 0.25 ml im | | Pending | | 90686 | | Iiv4 vacc no prsv 0.5 ml im | | $21.52 | | 90687 | | Iiv4 vaccine splt 0.25 ml im | | $10.24 | | 90688 | | Iiv4 vaccine splt 0.5 ml im | | $20.48 | | 90689* | | Vacc iiv4 no prsrv 0.25 ml im | | Pending | 90694 | | Quadrivalent(aIIV4) inactivated, adjuvanted, pres Cciiv4 vacc abx free im | | $30.58 | | Q2035* | | Afluria vacc, 3 yrs & >, im | | Pending | | Q2036* | | Flulaval vacc, 3 yrs & >, im | | Pending Please see IMPORTANT footnote below | | Q2037* | | Fluvirin vacc, 3 yrs & >, im | | Pending Please see IMPORTANT footnote below | | Q2038* | | Fluzone vacc, 3 yrs & >, im | | Pending Please see IMPORTANT footnote below | | Q2039 | | Influenza virus vaccine, nos | | Specify Drug Name; May Require Invoice * Important: Please verify coding where a fee is pending. This is usually an indication that there are no sources available to establish a fee. If billing a code with fee pending, you will need to provide a valid NDC for the current 2022/2023 flu season. Your claim will be rejected if incorrectly coded. The following HCPCS code to NDC crosswalk is made available for your reference. Note that some sources listed in this crosswalk represent 2017/2018, 2018/2019, 2019/2020. 2021/2022 and 2022/2023 flu season vaccines. These resources could be rejected if provided during the current 2022/2023 flu season. This information is also located on the [CMS website](https://www.cms.gov/medicare/medicare-part-b-drug-average-sales-price/2022-asp-drug-pricing-files). Excerpt from CMS file: Oct 2022 | Codes | Short Descriptor | | Labeler Name | | NDC | | Drug Name | | 90630 | | Flu vacc iiv4 no preserv id | (2017/2018) | | 90653 | | Iiv adjuvant vaccine im | | Seqirus Inc. | | 70461-0018-03 | | Fluad (Preservative Free) (2018/2019) | | 90653 | | Liv adjuvant vaccine im | | Seqirus Inc. | | 70461-0019-03 | | Fluad (2019/2020) | | 90653 | | Liv adjuvant vaccine im | | Seqirus Inc. | | 70461-0020-03 | | Fluad (2020/2021) | | 90656 | | IIV3 VACC NO PRSV 0.5 ML IM | | Seqirus Inc. | | 33332-0018-01 | | Afluria (Preservative Free) (2018/2019) | | 90662 | | Iiv no prsv increased ag im | | Sanofi Pasteur | 49281-0403-65 | | Fluzone | | prsv increased | | | | Fluzone | 90662 | | Liv no prsv increased ag im | | Sanofi Pasteur | 49281-0122-65 | | Fluzone | | 90662 | | no prsv increased ag im | | Sanofi Pasteur | | 49281-0403-65 | | Fluzone | 90662 | | Iiv no prsv increased ag im | | Sanofi | | | | 90662 | | prsv increased ag im | | Sanofi | | | | intranasal | | MedImmune, LLC | | 66019-0305-10 | | FluMist Quadrivalent (2018/2019) | | 90672 | | Laiv4 vaccine intranasal | | MedImmune, LLC | | 66019-0306-10 | | FluMist Quadrivalent (2019/2020) | | 90672 | | Laiv4 vaccine intranasal | | MedImmune, LLC | | 66019-0307-10 | | FluMist Quadrivalent (2020/2021) | | 90672 | | Laiv4 vaccine intranasal | | MedImmune, LLC | | 66019-0308-10 | | Quadrivalent | 90674 | | CCIIV4 VAC NO PRSV 0.5 ML IM | | Seqirus Inc. | | 70461-0318-03 | | Flucelvax Quadrivalent | | VAC NO PRSV 0.5 ML IM | | Seqirus Inc. | | 70461-0319-03 | | Flucelvax Quadrivalent | | VAC NO PRSV 0.5 ML IM | | Seqirus Inc. | | 70461-0320-03 | | Flucelvax Quadrivalent | | VAC NO PRSV 0.5 ML IM | | Seqirus Inc. | | 70461-0321-03 | | Flucelvax Quadrivalent | | VAC NO PRSV 0.5 ML IM | | Seqirus Inc. | | 70461-0322-03 | | Flucelvax Quadrivalent (2022/2023) | | 90682 | VACC RECOMBINANT DNA IM | | Pasteur 49281-0718-10 | | Flublok | | 90682 | VACC RECOMBINANT DNA IM | | Pasteur | 49281-0719-10 | | | 90682 | RIV4 VACC DNA IM | | Pasteur | 49281-0720-10 | | | 90682 | RIV4 VACC DNA IM | | Pasteur | 49281-0721-10 | | | 90682 | RIV4 VACC DNA IM | | Pasteur 49281-0722-10 | | Flublok | | NO PRSV 0.25 ML IM | | Sanofi | | 49281-0518-25 | | Fluzone Quadrivalent 90685 | | IIV4 VACC NO PRSV 0.25 ML IM | | | | | | NO PRSV 0.25 ML IM | | Seqirus | | 33332-0219-20 | | Afluria Quadrivalent NO PRSV 0.25 ML IM | | | VACC NO PRSV 0.25 ML IM | | Seqirus | | 33332-0220-20 | | Afluria Quadrivalent NO PRSV 0.25 ML IM | | | VACC NO PRSV 0.25 ML IM | | Seqirus | | 33332-0221-20 | | Afluria Quadrivalent VACC NO PRSV 0.5 ML IM | | Seqirus Inc. | | 33332-0318-01 | | Afluria Quadrivalent | | VACC NO PRSV 0.5 ML IM | | GlaxoSmithKline | 58160-0898-52 | | Fluarix Quadrivalent | | VACC NO PRSV 0.5 ML IM | | GlaxoSmithKline | 19515-0909-52 | | Flulaval Quadrivalent | | NO PRSV 0.5 ML IM | | | 49281-0418-50 | | Fluzone | | NO PRSV 0.5 ML IM | | | 49281-0418-10 | | Fluzone | | VACC NO PRSV 0.5 ML IM | | GlaxoSmithKline | 58160-0896-52 | | Fluarix Quadrivalent | | VACC NO PRSV 0.5 ML IM | | GlaxoSmithKline | 19515-0906-52 | | Flulaval Quadrivalent | | NO PRSV 0.5 ML IM | | | 49281-0419-50 | | Fluzone | | NO PRSV 0.5 ML IM | | | 49281-0419-10 | | Fluzone | | VACC NO PRSV 0.5 ML IM | | Seqirus Inc. | | 33332-0319-01 | | Afluria Quadrivalent | | VACC NO PRSV 0.5 ML IM | | GlaxoSmithKline | 58160-0885-52 | | Fluarix Quadrivalent | | VACC NO PRSV 0.5 ML IM | | GlaxoSmithKline | 19515-0816-52 | | Flulaval Quadrivalent | | NO PRSV 0.5 ML IM | | | 49281-0420-50 | | Fluzone | | NO PRSV 0.5 ML IM | | | 49281-0420-10 | | Fluzone | | VACC NO PRSV 0.5 ML IM | | Seqirus Inc. | | 33332-0320-01 | | Afluria Quadrivalent | | VACC NO PRSV 0.5 ML IM | | GlaxoSmithKline | 58160-0887-52 | | Fluarix Quadrivalent | | IIV4 VACC NO PRSV 0.5 ML IM | | ID Biomedical Corp | | 19515-0818-52 | | Flulaval Quadrivalent (Preservative Free) | | NO PRSV 0.5 ML IM | | | 49281-0421-50 | | Fluzone | | NO PRSV 0.5 ML IM | | | 49281-0421-10 | | Fluzone | | VACC NO PRSV 0.5 ML IM | | Seqirus Inc. | | 33332-0321-01 | | Afluria Quadrivalent | | VACC NO PRSV 0.5 ML IM | | | 58160-0890-52 | | Fluarix Quadrivalent | | VACC NO PRSV 0.5 ML IM | | | 19515-0808-52 | | Fluarix Quadrivalent | | NO PRSV 0.5 ML IM | | | 49281-0422-50 | | Fluzone | | NO PRSV 0.5 ML IM | | | 49281-0422-10 | | Fluzone | | VACC NO PRSV 0.5 ML IM | | | 33332-0322-03 | | Afluria Quadrivalent (2022/2023) | | 90687 | | VACCINE SPLT 0.25 ML IM | | Sanofi Pasteur | | 49281-0629-15 | | Fluzone | 90687 | | IIV4 VACCINE SPLT 0.25 ML IM | | Sanofi | | | | 90687 | | IIV4 VACCINE SPLT 0.25 ML IM | | Seqirus Inc. | | 3332-0419-10 | | Afluria Quadrivalent | | 90687 | | SPLT 0.25 ML IM | | Sanofi | | | | 90687 | | IIV4 VACCINE SPLT 0.25 ML IM | | Seqirus Inc. | | 33332-0420-10 | | Afluria Quadrivalent | | 90687 | | SPLT 0.25 ML IM | | Sanofi | | | | 90687 | | IIV4 VACCINE SPLT 0.25 ML IM | | Seqirus Inc. | | 33332-0421-10 | | Afluria Quadrivalent | | 90687 | | SPLT 0.25 ML IM | | Sanofi | | | | 90687 | | IIV4 VACCINE SPLT 0.25 ML IM | | Seqirus | | 33332-0422-10 | | Afluria Quadrivalent | 90688 | | IIV4 VACCINE SPLT 0.5 ML IM | | Seqirus Inc. | | 33332-0418-10 | | Afluria Quadrivalent (2018/2019) | | 90688 | | IIV4 VACCINE SPLT 0.5 ML IM | | GlaxoSmithKline | | 19515-0900-11 | | Flulaval Quadrivalent (2018/2019) | | 90688 | | IIV4 VACCINE SPLT 0.5 ML IM | | Sanofi Pasteur | | 49281-0629-15 | | Fluzone | 90688 | | IIV4 VACCINE SPLT 0.5 ML IM | | GlaxoSmithKline | | 19515-0897-11 | | Flulaval Quadrivalent (2019/2020) | | 90688 | | IIV4 VACCINE SPLT 0.5 ML IM | | Sanofi Pasteur | | 49281-0631-15 | | Fluzone | 90688 | | IIV4 VACCINE SPLT 0.5 ML IM | | Seqirus Inc. | | 33332-0419-10 | | Afluria Quadrivalent (2019/2020) | | 90688 | | IIV4 VACCINE SPLT 0.5 ML IM | | Sanofi Pasteur | | 49281-0633-15 | | Fluzone | 90688 | | IIV4 VACCINE SPLT 0.5 ML IM | | Seqirus Inc. | | 33332-0420-10 | | Afluria Quadrivalent (2020/2021) | | 90688 | | IIV4 VACCINE SPLT 0.5 ML IM | | Sanofi Pasteur | | 49281-0635-15 | | Fluzone | 90688 | | IIV4 VACCINE SPLT 0.5 ML IM | | Seqirus Inc. | | 33332-0421-10 | | Afluria Quadrivalent 0.5ML IM | 70461-0121-03 | | Fluad Quadrivalent (2021/2022) | | 90688 | | IIV4 VACCINE SPLT 0.5 ML IM | | Sanofi Pasteur | | 49281-0637-15 | | Fluzone | 90688 | | IIV4 VACCINE SPLT 0.5 ML IM | | Seqirus Inc. | | 33332-0422-10 | | Afluria Quadrivalent 0.5ML IM | 70461-0120-03 | | Fluad Quadrivalent 0.5ML IM | 70461-0120-03 | | Fluad Quadrivalent 0.5ML IM | 70461-0122-03 | Fluad Quadrivalent VACC ABX FREE IM | | Inc. | 70461-0418-10 | | Flucelvax | 90756 CCIIV4 VACC FREE IM | | Inc. | 70461-0419-10 | | Flucelvax | 90756 CCIIV4 VACC FREE IM | | Inc. | 70461-0420-10 | | Flucelvax | 90756 CCIIV4 VACC FREE IM | | Inc. | 70461-0421-10 | | Flucelvax | 90756 CCIIV4 VACC FREE IM | | Inc. | 70461-0422-10 | | Flucelvax Quadrivalent (2022/2023) | | Q2035 | | Afluria vacc, 3 yrs & >, im | | Seqirus Inc. | | 33332-0118-10 | | Afluria (2018/2019) Disclaimer: The above list may not be all-inclusive. Please be sure you are providing vaccines appropriate for the current 2022/2023 flu season. Pneumococcal Vaccine National Fees The fees provided below are subject to change with each quarterly drug update. For current fees, please check the [CMS website](http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Part-B-Drugs/McrPartBDrugAvgSalesPrice/index.html). | | CPT\u00ae | | Description | | 1/01/22 | | 04/01/22 | | 07/01/22 | | 10/01/22 | | 90670 | | Pneumococcal vacc, 13 val im | | $241.38 | | $257.99 | | $257.99 | | $257.99 | | 90671 | | Pneumococcal Conj vacc, 15 val | | $246.20 | | $246.20 | | $246.20 | | $246.20 | | 90677 | | Pneumococcal Conj vacc, 20 val | | $264.74 | | $283.72 | | $283.72 | | $283.72 | | 90732 | | Pneumococcal vaccine | | $133.47 | | $133.47 | | $133.47 | | $133.47 Reference Documents - CR 12788 October 2022 Quarterly Average Sales Price [ASP] Medicare Part B Drug Pricing Files and Revisions to Prior Quarterly Pricing Files - CR 12685 July 2022 Quarterly Average Sales Price [ASP] Medicare Part B Drug Pricing Files and Revisions to Prior Quarterly Pricing Files - CR 12559 April 2022 Quarterly Average Sales Price [ASP] Medicare Part B Drug Pricing Files and Revisions to Prior Quarterly Pricing Files - CR 12469 January 2022 Quarterly Average Sales Price (ASP) Medicare Part B Drug Pricing Files and Revisions to Prior Quarterly Pricing Files - CR 12421 Influenza Vaccine Payment Allowances \u2014 Annual Update for 2021/2022 Season - CR 12439 Claims Processing Instructions for the New Pneumococcal "}